Healthcare-only platform spanning seed through IPO and beyond via public, private and credit/royalty arms; acts as a biotech IPO accelerator and validation, aiding NASDAQ/HKEX listings and confidential financings. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Led by Binance co-founder He Yi, the family-office-style firm presents founders direct access to a top-tier exchange operator, build-incubate-distribute loop (≈50 incubated startup ventures), BNB Chain and listing pathways. With a disciplined investment approach, the team drives value for both founders and investors.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Backs edge-technology founders, fund managers and ecosystem builders, delivering Opportunity Hub–integrated training (BTEI), capital pathways, and co-creation of place-based equity districts and wealth initiatives. The firm continues to build its presence across the venture capital landscape.
Cannabis-technology specialist investing in med‑tech, ag‑tech, SaaS, marketplaces and deep‑tech (not plant‑touching), active in US, Canada, Israel, led by Micah Tapman with 90+ cannabis deals. With a disciplined investment approach, the team drives value for both founders and investors.
